04/02/2024
3:21 PM | BioCryst Pharmaceuticals (Issuer)
Thackray Helen M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2024
3:32 PM | BioCryst Pharmaceuticals (Issuer)
HEGGIE THERESA (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/26/2024
6:05 AM | BioCryst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2024
8:02 AM | Avoro Capital Advisors LLC (Filed by)
BioCryst Pharmaceuticals (Subject)
| Form SC 13G | |
01/24/2024
4:23 PM | BioCryst Pharmaceuticals (Subject)
BlackRock Inc. (Filed by)
| Form SC 13G/A | |
01/24/2024
12:06 PM | BioCryst Pharmaceuticals (Subject)
STATE STREET CORP (Filed by)
| Form SC 13G/A | |
01/18/2024
4:21 PM | BioCryst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
|
01/08/2024
6:02 AM | BioCryst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/20/2023
3:40 PM | BioCryst Pharmaceuticals (Issuer)
Stonehouse Jon P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/20/2023
3:42 PM | BioCryst Pharmaceuticals (Issuer)
Thackray Helen M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/20/2023
3:33 PM | Barnes Alane P (Reporting)
BioCryst Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/20/2023
3:35 PM | BioCryst Pharmaceuticals (Issuer)
Doyle Anthony (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/20/2023
3:38 PM | BioCryst Pharmaceuticals (Issuer)
Gayer Charles K (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/18/2023
3:40 PM | BioCryst Pharmaceuticals (Issuer)
Gayer Charles K (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/18/2023
3:43 PM | BioCryst Pharmaceuticals (Issuer)
Stonehouse Jon P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/18/2023
3:47 PM | BioCryst Pharmaceuticals (Issuer)
Thackray Helen M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/18/2023
3:34 PM | Barnes Alane P (Reporting)
BioCryst Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/18/2023
3:37 PM | BioCryst Pharmaceuticals (Issuer)
Doyle Anthony (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/01/2023
3:42 PM | BioCryst Pharmaceuticals (Issuer)
MILANO VINCENT (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/01/2023
3:40 PM | BioCryst Pharmaceuticals (Issuer)
HEGGIE THERESA (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/01/2023
6:37 AM | BioCryst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/30/2023
8:04 AM | BioCryst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/08/2023
3:29 PM | BioCryst Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
11/03/2023
11:14 AM | BioCryst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/03/2023
11:16 AM | BioCryst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/02/2023
6:05 AM | BioCryst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/26/2023
8:36 AM | BioCryst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/05/2023
3:41 PM | BioCryst Pharmaceuticals (Issuer)
HEGGIE THERESA (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/05/2023
3:43 PM | BioCryst Pharmaceuticals (Issuer)
MILANO VINCENT (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/03/2023
6:04 AM | BioCryst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/11/2023
6:00 AM | BioCryst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/30/2023
6:33 AM | BioCryst Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
06/15/2023
3:40 PM | BioCryst Pharmaceuticals (Issuer)
Galson Steven K (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/15/2023
3:42 PM | BioCryst Pharmaceuticals (Issuer)
LEE KENNETH B JR (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/15/2023
3:43 PM | BioCryst Pharmaceuticals (Issuer)
LEVIN ALAN G (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/15/2023
3:50 PM | BioCryst Pharmaceuticals (Issuer)
Stonehouse Jon P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/15/2023
3:31 PM | BioCryst Pharmaceuticals (Issuer)
McKee Amy E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/15/2023
3:33 PM | BioCryst Pharmaceuticals (Issuer)
Hutson Nancy J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/15/2023
3:35 PM | BioCryst Pharmaceuticals (Issuer)
MILANO VINCENT (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/15/2023
3:37 PM | BioCryst Pharmaceuticals (Issuer)
SANDERS MACHELLE (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/15/2023
3:39 PM | ASELAGE STEVE (Reporting)
BioCryst Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Better than Bitcoin? The Biotech Stock with 46,751% Potential (Ad) 4x Better than Bitcoin
Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December. Get the name of the stock here >>> |
06/15/2023
3:28 PM | ABERCROMBIE GEORGE B (Reporting)
BioCryst Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/15/2023
3:29 PM | BioCryst Pharmaceuticals (Issuer)
HEGGIE THERESA (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/15/2023
9:19 AM | BioCryst Pharmaceuticals (Subject)
SANDERS MACHELLE (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/14/2023
10:32 AM | BioCryst Pharmaceuticals (Subject)
Hutson Nancy J (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/14/2023
6:02 AM | BioCryst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/02/2023
3:32 PM | BioCryst Pharmaceuticals (Issuer)
HEGGIE THERESA (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/03/2023
6:08 AM | BioCryst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
